KCNA5

From WikiMD's WELLNESSPEDIA

KCNA5 is a gene that encodes the protein Kv1.5, a voltage-gated potassium channel found in the heart and in smooth muscle cells. Mutations in this gene have been associated with atrial fibrillation and idiopathic pulmonary arterial hypertension.

Function[edit]

The KCNA5 gene encodes a member of the potassium channel, voltage-gated, shaker-related subfamily. This member contains six membrane-spanning domains with a shaker-type repeat in the fourth segment. It belongs to the delayed rectifier class, members of which allow nerve cells to efficiently repolarize following an action potential. The encoded protein, a functional channel capable of opening in response to changes in membrane voltage, controls the voltage-dependency of this channel.

Clinical significance[edit]

Mutations in the KCNA5 gene have been associated with atrial fibrillation, a common, sustained cardiac rhythm disturbance. Atrial fibrillation is characterized by disorganized atrial electrical activity and ineffective atrial contraction promoting blood stasis in the atria and reduces ventricular filling. It can result in palpitations, syncope, thromboembolic stroke, and congestive heart failure.

Mutations in KCNA5 have also been associated with idiopathic pulmonary arterial hypertension, a disease characterized by increased pulmonary vascular resistance leading to right ventricular failure and death. The disease has been associated with mutations in different genes, and it is usually severe and not responsive to therapy.

See also[edit]

References[edit]


External links[edit]

  • KCNA5 at the National Center for Biotechnology Information



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.